Publicaciones (21) Publicaciones de Cristina Calviño Suárez

2024

  1. Efficacy and safety of biological treatment for inflammatory bowel disease in elderly patients: Results from a GETECCU cohort

    Gastroenterologia y Hepatologia

2023

  1. Enfermedad inflamatoria intestinal

    Microbiota, probióticos y prebióticos: evidencia científica (Ergon), pp. 389-392

  2. Is Occupation a Risk Factor for Developing Inflammatory Bowel Disease? A Case–Control Study

    Crohn's and Colitis 360, Vol. 5, Núm. 4

  3. Managing ulcerative colitis after surgery

    Frontiers in Medicine

  4. Preoperative optimization of patients with inflammatory bowel disease: a multicentre study of EIGA Group

    JOURNAL OF CROHNS & COLITIS, Vol. 17, Núm. Supl 1, pp. I356

2022

  1. Adherence to endoscopic surveillance for advanced lesions and colorectal cancer in inflammatory bowel disease: an AEG and GETECCU collaborative cohort study

    Alimentary pharmacology & therapeutics, Vol. 55, Núm. 11, pp. 1402-1413

  2. Endoscopic Postoperative Recurrence in Crohn's Disease After Curative Ileocecal Resection with Early Prophylaxis by Anti-TNF, Vedolizumab or Ustekinumab: A Real-World Multicentre European Study

    Journal of Crohn's & colitis, Vol. 16, Núm. 12, pp. 1882-1892

  3. Radon exposure and inflammatory bowel disease in a radon prone area

    Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva, Vol. 114, Núm. 7, pp. 405-409

2021

  1. Effectiveness and Safety of Ustekinumab in Ulcerative Colitis: Real-world Evidence from the ENEIDA Registry

    Journal of Crohn's and Colitis, Vol. 15, Núm. 11, pp. 1846-1851

  2. Effectiveness of ustekinumab in fistulising perianal Crohn′s disease refractory or intolerant to anti-TNF

    Journal of Crohn's and Colitis, Vol. 15, Núm. Supplement_1, pp. S419-S420

  3. Impact of biological agents on postsurgical complications in inflammatory bowel disease: A multicentre study of geteccu

    Journal of Clinical Medicine, Vol. 10, Núm. 19

  4. Role of quality of life as endpoint for inflammatory bowel disease treatment

    International Journal of Environmental Research and Public Health, Vol. 18, Núm. 13

2020

  1. Diagnostic protocol for cholestasis

    Medicine (Spain), Vol. 13, Núm. 9, pp. 517-520

  2. Diagnostic protocol for oesophageal chest pain

    Medicine (Spain), Vol. 13, Núm. 7, pp. 401-404

  3. Pouchitis: Treatment dilemmas at different stages of the disease

    United European Gastroenterology Journal, Vol. 8, Núm. 3, pp. 256-262

  4. Protocolo diagnóstico de la colestasis

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 13, Núm. 9, pp. 517-520

  5. Protocolo diagnóstico del dolor torácico esofágico

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 13, Núm. 7, pp. 401-404

  6. Should We Investigate Respiratory Diseases in Inflammatory Bowel Disease Patients?

    Archivos de Bronconeumologia

  7. Varón de 87 años con impactación esofágica

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 13, Núm. 7, pp. 417-418

2019

  1. Bismuth-containing quadruple therapy versus concomitant quadruple therapy as first-line treatment for Helicobacter Pylori infection in an area of high resistance to clarithromycin: A prospective, cross-sectional, comparative, open trial

    Helicobacter, Vol. 24, Núm. 1